Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma.

about

Synchronous Papillary Carcinoma of Thyroid and Lung

P2860

Q57793710-F9302E39-29C5-4880-A848-D8C387FA7F87

P2860

Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma.

Item

http://www.wikidata.org/entity/Q38388372

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Strong expression of HBME-1 as ...... f papillary thyroid carcinoma.

@en

type

Item

label

Strong expression of HBME-1 as ...... f papillary thyroid carcinoma.

@en

prefLabel

Strong expression of HBME-1 as ...... f papillary thyroid carcinoma.

@en

P1476

Strong expression of HBME-1 as ...... of papillary thyroid carcinoma

@en

P2093

Dubravka S Cvejic

http://www.w3.org/2001/XMLSchema#string

Sonja A Selemetjev

http://www.w3.org/2001/XMLSchema#string

Svetlana B Savin

http://www.w3.org/2001/XMLSchema#string

Tijana M Isic Dencic

http://www.w3.org/2001/XMLSchema#string

Vesna D Bozic

http://www.w3.org/2001/XMLSchema#string

Vladan R Zivaljevic

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer treatment and survivorship statistics, 2012

Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis.

Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach.

The meanings of markers: ancillary techniques in diagnosis of thyroid neoplasia.

Three cases of macrofollicular variant of papillary thyroid carcinoma

Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications.

Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules.

Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas.

Thyroid cancer epidemiology and prognostic variables.

Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors.

P2888

s12253-014-9883-6

P304

735-742

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12253-014-9883-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Svetlana Paskas

P577

2015-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270765321

http://www.w3.org/2001/XMLSchema#string

P698

25577274

http://www.w3.org/2001/XMLSchema#string

Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma.

about

P2860

P2860

Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698